News | November 12, 2014

Mevion Medical Systems Delivers Proton Accelerator to UF Health Cancer Center

Accelerator is core component of high-tech proton beam therapy system to treat cancer in adults and children

Mevion Medical Systems, proton beam therapy, proton accelarator, Mevian S250

The Mevion S250 accelerator, being lifted by a crane as it is delivered to the UF Health Cancer Center. Photo: Orlando Health

Nov. 12, 2014 — Mevion Medical Systems will deliver  its Mevion S250 proton therapy superconducting synchrocyclotron accelerator to the University of Florida Health Cancer Center at Orlando Health. The accelerator will treat cancer in adults and children.

Proton therapy precisely delivers radiation doses to tumors while sparing much of the surrounding healthy tissue, thus making it ideal for treating pediatric patients, as well as adult cancers in sensitive locations such as near the heart or brain. As Central Florida’s most advanced cancer center, the UF Health Cancer Center – Orlando Health is the first hospital in the region to install a proton therapy system. Installation of the accelerator will take just a few days, and construction of the proton center is expected to be completed next year.

The MEVION S250 is a proton therapy platform. It requires less space and has lower capital and operational costs than traditional systems. Also, it is a flexible solution; any health care organization can install one single-room Mevion proton thereapy system, or as many as they need to treat their patient population.

Like the rest of the Mevion S250 system, the accelerator itself is highly advanced, compact, patented technology. Due to its small size, it is the only proton beam cyclotron accelerator that can easily be delivered and installed. Consequently, its journey from Mevion’s Boston area headquarters to Orlando was a simple drive down I-95. Designed and manufactured in the United States, the accelerator delivered to Orlando is one of only six in the entire world.

The first Mevion S250 was installed last December at the Kling Center for Proton Therapy at Barnes-Jewish Hospital at Washington University in St. Louis, Mo., and is already treating more than 20 pediatric and adult cancer patients per day. The system is running with 97% uptime.

Five additional Mevion S250s are under installation at Robert Wood Johnson University Hospital in New Brunswick, N.J.; Stephenson Cancer Center at the University of Oklahoma in Oklahoma City, Okla.; Ackerman Cancer Center in Jacksonville, Fla.; University Hospitals Seidman Cancer Center in Cleveland, Ohio; and MedStar Georgetown University Hospital in Washington, D.C.

For more information:

Related Content

IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
Netherlands Proton Therapy Center Delivers First Clinical Flash Irradiation
News | Proton Therapy | May 02, 2019
IBA (Ion Beam Applications SA) recently announced the first Flash irradiation in an IBA proton therapy gantry treatment...
Pencil Beam Scanning Better Protects Children With Brain Tumors
News | Proton Therapy | May 01, 2019
A comparison of three types of radiotherapy for children's brain tumors suggests a type of proton therapy called pencil...
California Protons Cancer Therapy Center Begins Breast Cancer Study Enrollment
News | Proton Therapy | April 25, 2019
California Protons Cancer Therapy Center announced two major efforts representing significant steps forward in breast...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...
What to Expect from the Proton Therapy Market in 2019-2020
News | Proton Therapy | March 13, 2019
The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018, according to a new...
Videos | Proton Therapy | March 01, 2019
ITN Associate Editor Jeff Zagoudis speaks with Mark Pankuch, Ph.D., director of physics and dosimetry at the...
Videos | Proton Therapy | February 28, 2019
ITN Associate Editor Jeff Zagoudis speaks with ...
360 Photos | 360 View Photos | February 28, 2019
This is a 360 photo view behind the gantry room at the ...